Diplomat Announces 2nd Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
Diplomat Pharmacy (DPLO) Tops Q2 EPS by 4c; Raises Outlook
August 3, 2015 4:21 PM EDTDiplomat Pharmacy (NYSE: DPLO) reported Q2 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $808 million versus the consensus estimate of $738.99 million.
Diplomat Pharmacy sees FY2015 EPS of $0.56-$0.60, versus prior guidance of $0.48-$0.51 and the consensus of... More
